Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(2):193-200
The prospective study of 19 children (aged of 1 to 17 years) with invasive fungal infections and different forms of immunosupression was conducted. Clinical and microbiological efficacy and safety of caspofungin, as well as analysis of direct costs …